Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 06.11.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 12.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | f the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of |
| 28.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | f the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of |
| 23.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ated offering expenses payable by the Company. Item 5.02. Departure of Directors or Certain Officers; Election of Direct |
| 08.12.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointme |
| 24.10.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointme |
| 08.09.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment o |
| 03.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of |
Stammdaten
Unternehmen & Branche
| Name | Renalytix plc |
|---|---|
| Ticker | RNLXY |
| CIK | 0001811115 |
| Boerse | US |
| SIC | 8071 · Services-Medical Laboratories |
Wertpapier & Kennzahlen
| CUSIP | 75973T101 |
|---|---|
| ISIN | US75973T1016 |
| Typ | ADR |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2024-09-30 | 10-Q | 522,000 | -4,728,000 | -0.04 | 4,794,000 | -11,319,000 |
| 2024-06-30 | 10-K | 2,289,000 | -33,456,000 | -0.31 | 7,972,000 | -7,854,000 |
| 2024-03-31 | 10-Q | 535,000 | -7,743,000 | -0.08 | 8,769,000 | -11,111,000 |
| 2023-12-31 | 10-Q | 709,000 | -8,485,000 | -0.09 | 11,276,000 | -7,956,000 |
| 2023-09-30 | 10-Q | 459,000 | -10,154,000 | -0.11 | 19,540,000 | -1,491,000 |
| 2023-06-30 | 10-K | 3,403,000 | -45,607,000 | -0.55 | 30,629,000 | 6,967,000 |
| 2023-03-31 | 10-Q | 724,000 | -12,106,000 | -0.14 | 18,097,000 | |
| 2022-12-31 | 10-Q | 1,192,000 | -10,444,000 | -0.14 | 8,885,000 | |
| 2022-09-30 | 10-Q | 969,000 | -11,953,000 | -0.16 | 18,843,000 | |
| 2022-06-30 | 10-K | 2,970,000 | -45,276,000 | -0.67 | 50,065,000 | 30,607,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 30.09.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| Ironwood Investment Counsel, LLC | 10,000 | 2,630 | 100.00 |